Ryan Martin Phelan

Title: Ryan Martin Phelan: Innovator in Enzyme Research

Introduction

Ryan Martin Phelan is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of enzyme research, particularly in the study of carbapenems. With a total of 2 patents, Phelan's work has implications for antibiotic development and biochemistry.

Latest Patents

Phelan's latest patents focus on the ThnG and ThnQ enzymes encoded by the thienamycin gene cluster. These enzymes are responsible for the oxidation of the C-2 and C-6 moieties of carbapenems. ThnQ stereospecifically hydroxylates PS-5, resulting in the production of N-acetyl thienamycin. Meanwhile, ThnG catalyzes the sequential desaturation and sulfoxidation of PS-5, yielding PS-7 and its sulfoxide. The substrate selectivity of ThnG and ThnQ contributes to the oxidative diversity of carbapenems, showcasing their potential in antibiotic applications.

Career Highlights

Phelan is affiliated with Johns Hopkins University, where he continues to advance his research in enzymology. His work has garnered attention for its innovative approach to understanding enzyme functions and their applications in medicine.

Collaborations

Some of Phelan's notable coworkers include Craig Arthur Townsend and Micah Jeffrey Bodner. Their collaborative efforts contribute to the ongoing research and development in the field of enzyme studies.

Conclusion

Ryan Martin Phelan's contributions to enzyme research and his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in antibiotic development and biochemistry.